Implantable biocompatible expander suitable for treatment of constrictions of body lumen
An implantable biocompatible expander suitable for implantation into a urinary duct, comprises an elongated sinusoidal ring comprising at least two proximal prongs and at least two distal prongs, wherein the expander is resiliently deformable from a relaxed radially expanded orientation to a radially contracted orientation suitable for transluminal delivery through the urinary duct. The expander is configured to exert an outward radial force against a wall of the urinary duct when in-situ within the urinary duct. In particular, the expander is suitable for treatment of benign prostatic hyperplasia and configured for implantation into the prostatic urethra between, and substantially spanning the prostatic urethra between, the bladder neck and external sphincter.
1. An implantable biocompatible expander suitable for treatment of benign prostatic hyperplasia (BPH), the expander comprising: a single elongated undulating ring having a proximal end comprising three proximal prongs, each proximal prong having a respective apex, and a distal end comprising three distal prongs, each distal prong having a respective distal apex, wherein the expander is resiliently deformable from a relaxed radially expanded configuration to a radially contracted configuration suitable for transluminal delivery through the urethra, respective longitudinal struts connecting each of the proximal apices to two of the distal apices and each of the distal apices to two of the proximal apices, whereby the expander is configured to span a substantial section of the prostatic urethra between the bladder neck and external sphincter and cause in-situ expansion of the substantial section of the prostatic urethra and whereby the expander has a triangular cross-sectional shape configured to match the triangular cross section of the prostatic urethra such that, in-situ, the proximal prongs are configured to sit in the most lateral triangular recesses of the prostatic urethra and the longitudinal struts are configured to engage the wall of the prostatic urethra.
2. An implantable biocompatible expander according to claim 1 in which the single elongated undulating ring is a single elongated sinusoidal ring.
3. An implantable biocompatible expander according to claim 1 having an anchoring element configured to anchor the expander in the prostatic urethra during use, in which at least a part of the anchoring element is biodegradable to facilitate release of the expander after a period of time.
4. An implantable biocompatible expander according to claim 3 in which the anchoring element comprises a strut-embracing collar and one or more projections extending proud of the collar.
5. An implantable biocompatible expander according to claim 1 in which the distal and proximal prongs are staggered angularly around the ring such that the distal and proximal prongs alternate with each other circumferentially.
6. An implantable biocompatible expander according to claim 1 wherein at least one of the distal and proximal apices comprises a loop or lip.
7. An implantable biocompatible expander according to claim 6 in which the loop or lip projects radially into the expander or radially out of the expander.
8. An implantable biocompatible expander according to claim 1 in which the elongated undulating ring is tapered inwardly at each end such that the expander is substantially barrel shaped.
9. An implantable biocompatible expander according to claim 1 in which the undulating ring comprises open areas between the longitudinal struts and the distal and proximal prongs, wherein a radially outwardly facing surface area of the prongs and struts is less than 5% of the total open areas.
10. An implantable biocompatible expander according to claim 1 in which the undulating ring is formed from wire having a cross-sectional diameter of 0.2 to 1.0 mm.
11. An implantable biocompatible expander according to claim 1 in which the undulating ring is formed from a single wire.
12. An implantable biocompatible expander according to claim 11 in which one end of the wire is configured to form an anchoring element.
13. An implantable biocompatible expander according to claim 1 , in which the expander is configured to effect in-situ dilation of the prostatic urethra at the target location without blocking the verumontanum.
14. An implantable biocompatible expander according to claim 1 , having a width at the proximal or distal end of from 6 mm to 30 mm when in the radially expanded configuration and a length between the proximal apices and the distal apices of from 10 mm to 45 mm.
15. An implantable biocompatible expander according to claim 1 , wherein the expander has a length configured to span at least 50% of the length of the prostatic urethra between the bladder neck and the external sphincter.
16. An implantable biocompatible expander according to claim 1 , wherein when in the contracted configuration, the expander has a cross-sectional area that is reduced by 70% or more compared to the cross-sectional area of the expander when in the relaxed configuration.
17. An implantable biocompatible expander according to claim 1 , wherein a mutually-adjacent pair of longitudinal struts diverge proximally from one of the distal apices to create an open area between that pair of struts for, in-situ, accommodating the verumontanum between the struts of that pair.
18. An implantable biocompatible expander according to claim 1 , wherein the longitudinal struts splay longitudinally away from the prongs.
19. An implantable biocompatible expander suitable for treatment of benign prostatic hyperplasia (BPH), wherein:
the expander comprises a single elongated undulating ring having a proximal end comprising three proximal prongs, each proximal prong having a respective proximal apex, and a distal end comprising three distal prongs, each distal prong having a respective distal apex;
the expander is resiliently deformable from a relaxed radially expanded configuration to a radially contracted configuration suitable for transluminal delivery through the urethra;
respective longitudinal struts connect each of the proximal apices to two of the distal apices and each of the distal apices to two of the proximal apices, whereby the expander is configured to span a substantial section of the prostatic urethra between the bladder neck and the external sphincter and cause in-situ expansion of the substantial section of the prostatic urethra; and
a mutually-adjacent pair of the longitudinal struts diverge proximally from one of the distal apices to create an open area between that pair of struts for, in-situ, accommodating the verumontanum between the struts of that pair.
20. The biocompatible implantable expander of claim 19 , wherein the expander has a triangular cross sectional shape configured to match the triangular cross section of the prostatic urethra such that, in-situ, the proximal prongs are configured to sit in the most lateral triangular recesses of the prostatic urethra.